| Justin Sasser, OD | |
|
4700 Millhave Road #1090, Monroe, LA 71203 | |
| (318) 325-4598 | |
| (318) 325-4924 |
| Full Name | Justin Sasser |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 4700 Millhave Road #1090, Monroe, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528148251 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1535 (Louisiana) | Primary |
| Provider Name | Mark Lynn Od And Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417055203 PECOS PAC ID: 4688679269 Enrollment ID: O20061004000066 |
News Archive
Smoking is an important risk factor for developing the most common form of rheumatoid arthritis and other inflammatory diseases, but a critical question remains: Can those who quit smoking delay or prevent RA or have they permanently and irrevocably altered their risk of the disease? A new study by investigators from Brigham and Women's Hospital leverages data from the Nurses' Health Studies to find out.
VeriChip Corporation ("VeriChip") and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing partnership with RECEPTORS to continue the development of a triage detection system for detection of the H1N1 virus.
The team behind Clinical Conductor is proud to announce brand new enhancements to the industry-leading CTMS. This first oncology focused release of several in the coming quarters adds a multitude of advanced features and functionalities designed to optimize the management and execution of oncology studies at organizations of all sizes and makeups.
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.
› Verified 6 days ago
| Provider Name | Ga Doctors Of Optometry Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174105936 PECOS PAC ID: 7719375419 Enrollment ID: O20211221000300 |
News Archive
Smoking is an important risk factor for developing the most common form of rheumatoid arthritis and other inflammatory diseases, but a critical question remains: Can those who quit smoking delay or prevent RA or have they permanently and irrevocably altered their risk of the disease? A new study by investigators from Brigham and Women's Hospital leverages data from the Nurses' Health Studies to find out.
VeriChip Corporation ("VeriChip") and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing partnership with RECEPTORS to continue the development of a triage detection system for detection of the H1N1 virus.
The team behind Clinical Conductor is proud to announce brand new enhancements to the industry-leading CTMS. This first oncology focused release of several in the coming quarters adds a multitude of advanced features and functionalities designed to optimize the management and execution of oncology studies at organizations of all sizes and makeups.
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Sasser, OD 11103 West Avenue, Ste 6, San Antonio, TX 78213 Ph: (210) 524-6803 | Justin Sasser, OD 4700 Millhave Road #1090, Monroe, LA 71203 Ph: (318) 325-4598 |
News Archive
Smoking is an important risk factor for developing the most common form of rheumatoid arthritis and other inflammatory diseases, but a critical question remains: Can those who quit smoking delay or prevent RA or have they permanently and irrevocably altered their risk of the disease? A new study by investigators from Brigham and Women's Hospital leverages data from the Nurses' Health Studies to find out.
VeriChip Corporation ("VeriChip") and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing partnership with RECEPTORS to continue the development of a triage detection system for detection of the H1N1 virus.
The team behind Clinical Conductor is proud to announce brand new enhancements to the industry-leading CTMS. This first oncology focused release of several in the coming quarters adds a multitude of advanced features and functionalities designed to optimize the management and execution of oncology studies at organizations of all sizes and makeups.
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.
› Verified 6 days ago
Dr. Robert Dale Cagnolatti, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1812 Roselawn Ave, Monroe, LA 71201 Phone: 318-387-9626 Fax: 318-325-9425 | |
Dr. Elvis Surles, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2209 Forsythe Ave, Monroe, LA 71201 Phone: 318-387-5657 Fax: 318-325-8472 | |
Dr. Joseph Carter Moss, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2209 Forsythe Ave, Monroe, LA 71201 Phone: 318-387-5657 Fax: 318-325-8472 | |
Family Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 3000 Forsythe Ave, Monroe, LA 71201 Phone: 318-807-2020 Fax: 318-388-1868 | |
Dr. Michael J Haynes, O. D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2808 Forsythe Ave, Monroe, LA 71201 Phone: 318-323-4994 Fax: 318-388-6913 | |
Dr. William David Gordon, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3000 Forsythe Ave, Monroe, LA 71201 Phone: 318-325-9474 Fax: 318-388-1868 |